Claude Preudhomme Selected Research

Lenalidomide (CC 5013)

2/2016

Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claude Preudhomme Research Topics

Disease

55	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2005
16	Leukemia 01/2022 - 06/2007
13	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 04/2008
11	Residual Neoplasm 01/2021 - 11/2012
11	Neoplasms (Cancer) 01/2021 - 12/2004
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 08/2002
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 08/2002
4	Thrombocytopenia (Thrombopenia) 01/2019 - 02/2011
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2019 - 03/2005
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 12/2017 - 08/2017
3	Anemia 12/2017 - 07/2013
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2021 - 03/2014
2	Philadelphia Chromosome 01/2020 - 02/2006
2	Lymphoma (Lymphomas) 12/2019 - 05/2013
2	GATA2 Deficiency 01/2019 - 01/2019
2	Pdgfra-Associated Chronic Eosinophilic Leukemia 09/2013 - 06/2007
1	VEXAS syndrome 01/2022
1	Clinical Deterioration 07/2020
1	COVID-19 07/2020
1	Acute Promyelocytic Leukemia 01/2018
1	Pathologic Complete Response 01/2018
1	Hemorrhage 01/2018
1	Myeloid Sarcoma (Chloroma) 01/2018
1	Multiple Myeloma 12/2017
1	Cytopenia 12/2017
1	Iron Overload 12/2017
1	Monoclonal Gammopathy of Undetermined Significance 10/2017
1	Hematologic Diseases (Blood Diseases) 12/2016
1	Fatigue 04/2016
1	Disease Progression 03/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2015

Drug/Important Bio-Agent (IBA)

15	Imatinib Mesylate (Gleevec)FDA Link 12/2013 - 08/2002
8	Gemtuzumab (Mylotarg)FDA Link 08/2020 - 04/2012
8	Core Binding Factors (Core-Binding Factor)IBA 12/2018 - 03/2009
7	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 04/2012
7	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2008
6	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2017 - 03/2009
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 08/2002
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019 - 08/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 04/2008
3	Phosphotransferases (Kinase)IBA 01/2021 - 04/2003
3	Dasatinib (BMS 354825)FDA Link 06/2015 - 12/2008
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2022
2	EnzymesIBA 01/2022 - 08/2010
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 08/2010
2	Biological ProductsIBA 07/2020 - 12/2016
2	Clofarabine (Clolar)FDA Link 12/2019 - 04/2017
2	NucleophosminIBA 10/2019 - 11/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2018 - 06/2015
2	Decitabine FDA Link 02/2016 - 10/2011
2	Interleukin-2 (IL2)IBA 01/2016 - 02/2010
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2013 - 02/2010
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2013 - 02/2010
2	CCAAT-Enhancer-Binding Protein-alphaIBA 12/2010 - 05/2009
1	SOXC Transcription FactorsIBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2020
1	Amino Acids FDA Link 12/2020
1	Biological FactorsIBA 07/2020
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2020
1	Antimitotic AgentsIBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	Asparaginase (Elspar)FDA Link 12/2019
1	Methotrexate (Mexate)FDA LinkGeneric 12/2019
1	Vincristine (Oncovin)FDA LinkGeneric 12/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019
1	Prednisone (Sone)FDA LinkGeneric 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 09/2019
1	guadecitabineIBA 01/2019
1	Polycomb Repressive Complex 2IBA 01/2018
1	ChromatinIBA 01/2018
1	CohesinsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Immunomodulating AgentsIBA 12/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017
1	IronIBA 12/2017
1	Deferasirox FDA Link 12/2017
1	Immunoglobulin M (IgM)IBA 10/2017
1	CholesterolIBA 12/2016
1	OTX015IBA 04/2016
1	BilirubinIBA 04/2016
1	CytidineIBA 02/2016
1	Lenalidomide (CC 5013)FDA Link 02/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	TetraspaninsIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 12/2015
1	Rituximab (Mabthera)FDA Link 07/2015

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2005
19	Drug Therapy (Chemotherapy) 01/2022 - 06/2005
4	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2017
3	Stem Cell Transplantation 01/2021 - 06/2012
2	Induction Chemotherapy 02/2010 - 06/2007
1	Ligation 10/2021
1	Critical Care (Surgical Intensive Care) 07/2020
1	Immunotherapy 01/2019
1	Transplantation 01/2018
1	Erythrocyte Transfusion 12/2017
1	Salvage Therapy 01/2017